Skip to main content
Clinical Trials/ISRCTN52683557
ISRCTN52683557
Completed
未知

Efficacy and safety of acupuncture in Chronic MIGraine - a multicentre, randomised, controlled clinical trial

Ruhr-University Bochum (Germany)0 sites1,295 target enrollmentAugust 2, 2005

Overview

Phase
未知
Intervention
Not specified
Conditions
Migraine
Sponsor
Ruhr-University Bochum (Germany)
Enrollment
1295
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2005
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ruhr-University Bochum (Germany)

Eligibility Criteria

Inclusion Criteria

  • 1\. Member of participating health insurance company
  • 2\. Age between 18 and 65
  • 3\. Signed informed consent
  • 4\. Ability to read and speak sufficient German
  • 5\. First migraine attack before the age of 50
  • 6\. First migraine diagnosis at least six months before
  • 7\. Two to six migraine attacks in four weeks
  • 8\. Duration of migraine attacks 4 to 72 hours without acute\-medication or at least 2 hours with acute\-medication
  • 9\. Two migraine characteristics have to be met, at least one accompaniment

Exclusion Criteria

  • 1\. Severe migraine\-attacks with inability to go to work on more than four days a month
  • 2\. Other neurological disease
  • 3\. Seconday headache
  • 4\. Neuralgia of the face or head
  • 5\. More than six days of non\-migrainous headache a month
  • 6\. Experience with acupuncture against migraine
  • 7\. Any acupuncture in the last 12 months
  • 8\. Previous unsuccessful therapy with beta\-blocker
  • 9\. Drug abuse
  • 10\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials